ARCHIVES

M.D. Anderson Closes Trials following FDA Requests for Data

This article is from The Cancer Letter archive.

Vol. 22 No. 07 | February 16, 1996

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves Concept For New $850,000 Year Grant Program To Study Viruses In Cervical Cancer

November 9, 1984

After A One-Month Retirement, Becker Returns To M.D. Anderson As Research Prof.

November 30, 2001

Group Chairmen Propose Adding Four Trials For High Priority Status

July 6, 1990

FDA Approves Arranon For Leukemia And Lymphoma

December 30, 2005

DRCCA Board, ACCI Agree On New Core Grant Guidelines

February 6, 1981

Cooperative Group Problems, Solutions Analyzed By CTEP Staff

May 2, 1986